IMB-881

N/A

Report date: 2023/01/14 18:58:06
NME

Base Information

Drug NameIMB-881
Drug Alias NameIMB-881
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipopolysaccharide (LPS) inhibitors
TargetsLipopolysaccharide (LPS)
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A